Australia; International; NSW; VIC
An international task force, which includes Australians, has outlined the circumstances in which it may be clinically indicated to take people off certain drugs used to treat mental illness. They say stopping medications, or deprescribing, should be considered when benefits are absent, or the risks outweigh benefits; and only after making sure patients are adhering to the medication, and after considering the psychosocial ramifications of stopping the medication. They also say that patients should be monitored closely. The task force panel called for systematic, periodic reviews of medications to make sure they remain relevant, that the benefits outweigh risks, and that patients assume an active collaborative role in shared decision-making.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
